These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2689186)
1. Human T cell-replacing factor(s): a comparison of recombinant and purified human B cell growth and differentiation factors. Smith SH; Shields JG; Callard RE Eur J Immunol; 1989 Nov; 19(11):2045-9. PubMed ID: 2689186 [TBL] [Abstract][Full Text] [Related]
2. T cell-replacing factor in specific antibody responses to influenza virus by human blood B cells. Callard RE; Booth RJ; Brown MH; McCaughan GW Eur J Immunol; 1985 Jan; 15(1):52-9. PubMed ID: 2578400 [TBL] [Abstract][Full Text] [Related]
3. Analysis of T cell-replacing factor-like activity: potent induction of T helper activity for human B cells by residual concanavalin A and interleukin 2. Sauerwein RW; Van der Meer WG; Aarden LA Eur J Immunol; 1987 Aug; 17(8):1145-50. PubMed ID: 2957215 [TBL] [Abstract][Full Text] [Related]
4. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells. Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718 [TBL] [Abstract][Full Text] [Related]
5. Interaction between cytokines and 8-mercaptoguanosine in humoral immunity: synergy with interferon. Goodman MG J Immunol; 1987 Jul; 139(1):142-6. PubMed ID: 3108396 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma. Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257 [TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 and low molecular weight B cell growth factor are T cell-replacing factors for different subpopulations of human B cells. Callard RE; Smith SH Eur J Immunol; 1988 Oct; 18(10):1635-8. PubMed ID: 3263924 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
9. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Lasky JL; Thorbecke GJ Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224 [TBL] [Abstract][Full Text] [Related]
10. Differentiation factors for human specific B cell response. Vazquez A; Gerard JP; Delfraissy JF; Dugas B; Auffredou MT; Crevon MC; Fradelizi D; Galanaud P Eur J Immunol; 1986 Jul; 16(7):803-8. PubMed ID: 3487460 [TBL] [Abstract][Full Text] [Related]
11. Antigen-nonspecific T cell-derived factors in B cell activation: differences in the requirements for interleukin 2 in responses of unprimed and primed B cells. Kuhara T; Haughton G; Corley RB Eur J Immunol; 1985 Aug; 15(8):787-93. PubMed ID: 3875491 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions. Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902 [TBL] [Abstract][Full Text] [Related]
13. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor. Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197 [TBL] [Abstract][Full Text] [Related]
14. Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation. Koyama N; Harada N; Takahashi T; Mita S; Okamura H; Tominaga A; Takatsu K Immunology; 1988 Feb; 63(2):277-83. PubMed ID: 3280472 [TBL] [Abstract][Full Text] [Related]
15. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907 [TBL] [Abstract][Full Text] [Related]
16. B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. Mingari MC; Gerosa F; Moretta A; Zubler RH; Moretta L Eur J Immunol; 1985 Feb; 15(2):193-6. PubMed ID: 3871701 [TBL] [Abstract][Full Text] [Related]
17. Enhancing effects of interleukin 2-treated peripheral blood mononuclear cells on subsequent B cell differentiation. Stohl W; Elliott JE; Wang H; Lin YG; Horwitz DA Cell Immunol; 1994 Sep; 157(2):381-92. PubMed ID: 8069923 [TBL] [Abstract][Full Text] [Related]
18. Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2. Burdach S; Shatsky M; Wagenhorst B; Levitt L J Immunol; 1987 Jul; 139(2):452-8. PubMed ID: 3110272 [TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha can synergize with interleukin 2 for human in vitro antibody response. Delfraissy JF; Wallon C; Galanaud P Eur J Immunol; 1988 Sep; 18(9):1379-84. PubMed ID: 3262520 [TBL] [Abstract][Full Text] [Related]
20. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay. Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]